Bronstein, Gewirtz & Grossman, LLC Is Investigating SelectQuote, Inc. (SLQT) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against SelectQuote, Inc. (NYSE:SLQT) on behalf of investors who purchased securities prior to September 9, 2020, and continue to hold them. The investigation concerns possible corporate wrongdoing by SelectQuote and its officers/directors. The law firm encourages affected shareholders to connect with them for more information and to assist in the investigation.
SelectQuote, Inc. (SLQT) Stock forecasts
This article provides a brief overview of SelectQuote, Inc. (SLQT) stock forecasts, highlighting an Argus quantitative report from June 2022. It mentions SLQT's role as a direct-to-consumer distribution platform for health and life insurance and lists related reports for another company, GTM, from early 2026. The article also includes various market data and other trending financial information.
SLQT PE Ratio & Valuation, Is SLQT Overvalued
SelectQuote Inc (SLQT) is currently in the "Fair zone" with a forward PS ratio of 0.14, which is considered fair compared to its five-year average. The fair price for SLQT is estimated to be between $0.58 and $0.97. Despite a P/S ratio of 0.06, which is above the industry average, its strong revenue growth of 11.65% suggests this premium may be unsustainable.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against SelectQuote, Inc. (SLQT) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by SelectQuote, Inc. (NYSE: SLQT) and its officers/directors. The firm is encouraging shareholders who purchased SelectQuote securities before September 9, 2020, and continue to hold them, to join the investigation. This class action aims to recover investor capital and ensure corporate accountability.
Book value per share of SelectQuote Inc – MUN:6SJA
The article focuses on the book value per share of SelectQuote Inc (MUN:6SJA) listed on the Munich Stock Exchange. It presents a page from TradingView displaying financial information for the company, specifically highlighting its book value per share. The page indicates that the market is closed and provides various data sources.
Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of SelectQuote, Inc. (NYSE: SLQT) stockholders who purchased securities prior to September 9, 2020, and continue to hold them. The investigation aims to determine if SelectQuote officers and/or directors engaged in corporate wrongdoing. Investors are encouraged to visit the firm's website or contact them for more information and to assist with the investigation.
SelectQuote (SLQT) price target decreased by 14.04% to 3.12
This article reports a 14.04% decrease in the price target for SelectQuote (SLQT), bringing it down to $3.12. The content provided is minimal, indicating only this change.
SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure
SelectQuote (SLQT) has received a notice from the NYSE for non-compliance, as its average share price fell below $1 for 30 consecutive trading days. The company has a six-month period to regain compliance, with management prepared to take shareholder-approved measures if necessary. Despite recent strong fiscal second-quarter results and a new $415 million credit facility, the stock faces pressure and analysts rate it a Hold with a $0.71 price target.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against SelectQuote, Inc. (SLQT) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by SelectQuote, Inc. (NYSE: SLQT). The firm is encouraging investors who purchased SelectQuote securities before September 9, 2020, and continue to hold them, to learn more and assist in the investigation. Investors can find additional information or contact the firm to participate.
SelectQuote receives NYSE notice over sub-$1 share price
SelectQuote (NYSE: SLQT) has received a notice from the New York Stock Exchange (NYSE) because its average stock price fell below $1.00 per share over a 30-consecutive trading day period. The company now has six months to regain compliance, which requires its stock to trade above $1.00 for at least 30 consecutive days. SelectQuote is exploring its options to address this non-compliance, including a reverse stock split.
SelectQuote receives NYSE notice over stock price compliance
SelectQuote Inc. (NYSE: SLQT) received a notice from the NYSE due to its common stock trading below $1.00 per share for 30 consecutive trading days. The company has a six-month cure period to regain compliance, needing its stock to close at or above $1.00 with an average closing price of at least $1.00 over the preceding 30 days. Despite the current low stock price and the delisting notice, InvestingPro analysis suggests the stock may be undervalued, and the company recently reported stronger-than-expected Q2 fiscal year 2026 earnings and launched a new franchise model.
SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure
SelectQuote (SLQT) has received a notice from the NYSE regarding non-compliance, as its average share price dropped below $1 for 30 consecutive trading days. The company has a six-month window to regain compliance, with management planning to leverage strong recent financial results, including a new $415 million credit facility, to support its position. Spark, TipRanks' AI Analyst, rates SLQT as Neutral, citing improving fundamentals and a constructive earnings outlook, but is tempered by weak technicals and inconsistent cash flow.
SelectQuote receives NYSE notice over sub-$1 share price
SelectQuote, an insurance comparison marketplace, announced it received a notice from the New York Stock Exchange due to its stock trading below the minimum $1.00 per share requirement. The company has six months to regain compliance, with a possible extension, by having its common stock's average closing price reach at least $1.00 over a consecutive 30 trading-day period. SelectQuote plans to notify the NYSE of its intention to cure the deficiency.
SelectQuote Disclosed Failure to Satisfy a Continued Listing Rule or Standard
SelectQuote (SLQT) received notice from the NYSE on March 19, 2026, for non-compliance with Section 802.01C due to its average closing price falling below $1.00 for 30 consecutive trading days. The company intends to rectify this deficiency within a six-month period, during which its stock will continue to trade on the NYSE. This information is based on an original SEC Filing (8-K) from March 25, 2026.
NYSE warns SelectQuote (NYSE: SLQT) on sub-$1 share price, company outlines cure and liquidity
SelectQuote (NYSE: SLQT) received a notice from the NYSE for failing to maintain a minimum average closing price of $1.00 per share over 30 consecutive trading days. The company has a six-month cure period, starting March 19, 2026, to regain compliance and plans to monitor its share price and consider actions, potentially requiring stockholder approval, to address the deficiency. SelectQuote also highlighted a new $415 million credit facility extending most debt maturities to 2031 and projected fiscal 2026 operating cash flow of $25 million to $35 million, which it believes supports its liquidity during this period.
SelectQuote, Inc. Announces Receipt of Continued Listing Standard Notice from NYSE; Plans to Take Appropriate Actions to Cure
SelectQuote, Inc. (NYSE: SLQT) has received a notice from the NYSE stating it is non-compliant with listing standards due to its average closing stock price falling below $1.00 for 30 consecutive trading days. The company intends to cure this deficiency within a six-month period and will monitor its stock price and take appropriate actions to maintain its NYSE listing. SelectQuote recently reported strong fiscal second-quarter 2026 results and secured a new $415 million credit facility, projecting robust operating cash flow.
SelectQuote, Inc. (SLQT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against SelectQuote, Inc. (NYSE:SLQT) on behalf of investors who purchased shares prior to September 9, 2020, and continue to hold them. The investigation focuses on whether the company and its officers engaged in corporate wrongdoing. Shareholders are encouraged to contact the firm to learn more and potentially assist in the investigation.
SelectQuote (NYSE:SLQT) Trading 11.4% Higher - What's Next?
SelectQuote (NYSE:SLQT) shares rose 11.4% on Monday, trading at $0.664 with increased volume. This surge follows a mixed analyst sentiment, with a consensus "Hold" rating but a wide range of individual recommendations and price targets. The company recently beat earnings per share and revenue estimates, though sell-side analysts project a negative EPS for the current fiscal year.
Deadline to Lead in Securities Class Action Against SelectQuote, Inc. (SLQT) is October 10, 2025 - Contact Kaplan Fox
Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against SelectQuote, Inc. (NYSE: SLQT) on behalf of investors who purchased securities between September 9, 2020, and May 1, 2025. The lawsuit alleges that SelectQuote made false or misleading statements and failed to disclose that it was receiving illegal kickbacks for steering Medicare beneficiaries to certain insurers. Investors have until October 10, 2025, to move the court to serve as a lead plaintiff.
Noble Financial Sticks to Its Buy Rating for SelectQuote (SLQT)
Noble Financial analyst Patrick McCann, CFA, has reiterated a Buy rating for SelectQuote (SLQT) and set a price target of $5.00. The company recently reported strong quarterly revenues of $537.1 million and a net profit of $69.29 million, an increase from the previous year. Insider sentiment for SelectQuote is positive, with an increase in insider buying over the last quarter.
Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims on behalf of SelectQuote, Inc. (NYSE:SLQT) stockholders who purchased shares prior to September 9, 2020. The firm is encouraging these investors to inquire about the investigation concerning possible corporate wrongdoing by SelectQuote's officers and directors. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to restore investor capital through class actions.
Kuehn Law Encourages Investors of SelectQuote, Inc. to Contact Law Firm
Kuehn Law, PLLC is investigating SelectQuote, Inc. (NYSE: SLQT) regarding potential breaches of fiduciary duties by its officers and directors. The investigation stems from allegations that the company misrepresented or failed to disclose practices related to steering Medicare beneficiaries to certain plans and receiving illegal kickbacks. Investors who purchased SLQT prior to September 9, 2020, are encouraged to contact the firm.
Kuehn Law Encourages Investors of SelectQuote, Inc. to Contact Law Firm
Kuehn Law, PLLC is investigating SelectQuote, Inc. (NYSE: SLQT) for alleged breaches of fiduciary duties to shareholders. A federal securities lawsuit claims SelectQuote misrepresented its Medicare plan recommendations, potentially receiving illegal kickbacks and violating regulations. Investors who purchased SLQT prior to September 9, 2020, are encouraged to contact the law firm.
SelectQuote launches franchise model for local insurance sales
SelectQuote, Inc. launched SelectQuote Local, a franchise model enabling local representatives to sell senior health and life insurance products. This initiative expands their existing distribution model, requiring low capital investment and expecting recurring royalty streams. The announcement comes as the stock trades near its 52-week low but after SelectQuote reported strong Q2 2026 earnings, surpassing analyst expectations.
SelectQuote launches franchise model for local insurance sales By Investing.com
SelectQuote, Inc. (NYSE: SLQT) has launched "SelectQuote Local," a franchise model designed to expand its distribution of senior health and life insurance products through local representatives. This new initiative aims to leverage the company's four decades of experience as an insurance brokerage while requiring low capital investment from the company and generating a recurring royalty stream. The announcement comes as SelectQuote's stock trades near its 52-week low, despite a recent report of second-quarter earnings exceeding analyst expectations.
SelectQuote introduces franchise model for local insurance distribution
This article is a placeholder with no content available. Therefore, a meaningful summary cannot be generated at this time.
SelectQuote launches franchise model for local insurance sales
SelectQuote (NYSE: SLQT) has introduced SelectQuote Local, a franchise model that allows local representatives to sell senior health and life insurance. This initiative aims to expand the company's distribution channels and provide a recurring royalty stream with low capital investment. Despite recent positive earnings, the company's stock is trading near its 52-week low.
SelectQuote launches franchise model for local insurance sales By Investing.com
SelectQuote, Inc. (NYSE:SLQT) has introduced SelectQuote Local, a franchise model that enables consumers to purchase senior health and life insurance through local representatives. This initiative expands the company's existing telephonic distribution, with franchise owners operating in specific geographic regions. The company, which recently reported strong Q2 2026 earnings, anticipates a recurring royalty stream with low capital investment, despite its stock trading near a 52-week low.
SelectQuote Announces SelectQuote Local, Adding a New Strategic Growth Channel to Its Industry-Leading Insurance Platform
SelectQuote, Inc. (NYSE: SLQT) is expanding its insurance distribution model by launching SelectQuote Local, a franchise model that allows consumers to meet with local representatives for senior health and life insurance products. This initiative aims to extend SelectQuote's reach to consumers who prefer in-person interactions while leveraging the company's existing marketing, technology, and carrier relationships. The company anticipates SelectQuote Local will provide a cash-efficient growth opportunity, creating a recurring royalty stream for shareholders, and complementing its growing SelectRx pharmacy and healthcare services business.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against SelectQuote, Inc. (SLQT) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential claims against SelectQuote, Inc. (NYSE: SLQT) regarding corporate wrongdoing. The firm is encouraging investors who purchased SelectQuote securities before September 9, 2020, and still hold them, to contact them to assist in the investigation. The firm operates on a contingency fee basis, only seeking reimbursement for expenses and fees if successful.
Bronstein, Gewirtz & Grossman, LLC Is Investigating SelectQuote, Inc. (SLQT) And Encourages Stockholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. (NYSE:SLQT) securities. The investigation, announced on March 15, 2026, concerns whether the company and its officers engaged in corporate wrongdoing. Investors who bought SelectQuote shares before September 9, 2020, and still hold them, are encouraged to contact the firm to assist with the inquiry.
SelectQuote, Inc. (SLQT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of SelectQuote, Inc. (NYSE: SLQT) investors. The investigation focuses on whether SelectQuote and its officers engaged in corporate wrongdoing, specifically for those who purchased securities before September 9, 2020, and continue to hold them. The firm encourages affected stockholders to contact them to learn more and potentially assist in the investigation, offering their services on a contingency fee basis.
SelectQuote Shareholders Sue Executives Over DOJ Kickback Suit
Shareholders of SelectQuote Inc. have filed lawsuits alleging that company executives and board members engaged in insider sales totaling $177 million while hiding that the company was receiving kickbacks for promoting Medicare Advantage plans. This legal action follows a Department of Justice False Claims Act complaint against SelectQuote and others for similar practices, which caused SelectQuote's share price to drop significantly. The lawsuits accuse the executives of self-enrichment at the expense of shareholders by concealing material information.
SelectQuote Shareholders Sue Executives Over DOJ Kickback Suit
Shareholders of SelectQuote Inc. have filed lawsuits against the company's executives and board members, alleging they made $177 million from insider sales while hiding that SelectQuote received kickbacks for promoting Medicare Advantage plans. This legal action follows a Department of Justice False Claims Act complaint publicized on May 1 of last last year, which caused SelectQuote's share price to drop over 19%. The lawsuits contend that executives concealed the alleged kickback scheme involving health insurers.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against SelectQuote, Inc. (SLQT) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by SelectQuote, Inc. (NYSE:SLQT) and its officers/directors. The firm is encouraging investors who purchased SelectQuote securities before September 9, 2020, and still hold them, to come forward and assist in the investigation. This investigation is being conducted on a contingency fee basis with no cost to the investors unless successful.
Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Investors to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. (NYSE:SLQT). The firm encourages investors who bought SelectQuote securities before September 9, 2020, and still hold them, to contact them to assist with the investigation into potential corporate wrongdoing. The firm operates on a contingency fee basis, meaning investors incur no upfront cost.
Kuehn Law Encourages Investors of SelectQuote, Inc. to Contact Law Firm
Kuehn Law is investigating SelectQuote, Inc. (NYSE: SLQT) following allegations that the company misrepresented its Medicare Advantage insurance plan practices, potentially breaching fiduciary duties to shareholders. The lawsuit claims SelectQuote directed beneficiaries to plans based on compensation rather than suitability, and may have received illegal kickbacks. Investors who purchased SLQT prior to September 9, 2020, are encouraged to contact Kuehn Law.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against SelectQuote, Inc. (SLQT) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims against SelectQuote, Inc. (NYSE: SLQT) for alleged corporate wrongdoing. The firm encourages shareholders who purchased SelectQuote securities prior to September 9, 2020, and still hold them, to come forward and assist in the investigation. They emphasize that there is no cost to investors as the firm operates on a contingency fee basis.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against SelectQuote, Inc. (SLQT) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by SelectQuote, Inc. (NYSE:SLQT). The firm is encouraging shareholders who purchased SelectQuote securities before September 9, 2020, and continue to hold them, to join the investigation. Investors can find more information and assist the investigation by visiting the firm's website or contacting their client relations team.
Director Chris Wolfe acquires 9,502 SelectQuote (SLQT) shares from RSU conversion
SelectQuote director Chris Wolfe acquired 9,502 shares of common stock through the conversion of restricted stock units on February 28, 2026. These shares were granted at $0.00 per share under SelectQuote’s 2020 Omnibus Incentive Plan. After the transaction, Wolfe directly holds 9,502 common shares and 19,006 restricted stock units, which vest in annual installments contingent on his continued Board service.
Board member at SelectQuote (SLQT) receives 106,250 RSUs and stock
SelectQuote director Srdjan Vukovic received a grant of 106,250 restricted stock units (RSUs) on November 11, 2025, and on February 28, 2026, 9,502 of these RSUs converted into common shares. These transactions, filed as a Form 4, show that after the conversion, he directly holds 19,006 RSUs and 9,502 common shares. The RSUs vest over time, contingent on his continued service on the Board of Directors.
SelectQuote, Inc. (NYSE:SLQT) Short Interest Update
Short interest in SelectQuote, Inc. (NYSE:SLQT) increased by 33.9% in February, reaching 3,318,984 shares, representing approximately 2.2% of the company's shares sold short. Despite quarterly earnings beating estimates, analysts project a full-year EPS of -$0.07, rating the stock as a "Moderate Buy" with a target price of $2.92. Institutional investors have also adjusted their positions, with notable increases from firms like AQR Capital Management LLC.
SelectQuote, Inc. (SLQT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by SelectQuote, Inc. (SLQT). The firm is encouraging investors who purchased SelectQuote securities prior to September 9, 2020, and continue to hold them, to contact them for more information and to assist in the investigation. The investigation focuses on whether SelectQuote and its officers/directors engaged in unlawful activities.
Bronstein, Gewirtz & Grossman, LLC Is Investigating SelectQuote, Inc. (SLQT) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against SelectQuote, Inc. (NYSE:SLQT) for alleged corporate wrongdoing. The firm encourages investors who purchased SelectQuote securities before September 9, 2020, and still hold them, to join the investigation. Investors can find more information and assist the investigation by visiting the firm's website or contacting their client relations manager.
SelectQuote Announces Participation in Upcoming Mizuho Virtual Healthcare Technology Conference on March 5
SelectQuote, Inc. (NYSE: SLQT) announced that its CEO, Tim Danker, and CFO, Ryan Clement, will participate in Mizuho’s 2026 Virtual Healthcare Technology Conference on March 5, 2026. The management will be available for investor meetings. SelectQuote is a leading distributor of Medicare insurance policies and operates a growing Healthcare Services platform.
Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is urging shareholders of SelectQuote, Inc. (SLQT) who purchased securities before September 9, 2020, and continue to hold them, to inquire about a securities investigation. The investigation focuses on potential corporate wrongdoing by SelectQuote and its officers/directors. The law firm operates on a contingency fee basis, seeking reimbursement only if successful in restoring investor capital and ensuring corporate accountability.
SelectQuote Announces Participation in Upcoming Mizuho Virtual Healthcare Technology Conference on March 5
SelectQuote, Inc. announced that its CEO, Tim Danker, and CFO, Ryan Clement, will participate in Mizuho's 2026 Virtual Healthcare Technology Conference on March 5, 2026. They will be available for investor meetings. The company, founded in 1985, is a leading distributor of Medicare insurance policies and has a growing Healthcare Services platform.
SelectQuote (SLQT) Price Target Decreased by 20.83% to 3.63
The average one-year price target for SelectQuote (SLQT) has been reduced by 20.83% to $3.63 per share from a previous estimate of $4.59. This new target represents a significant increase of 311.85% from the current closing price of $0.88 per share. Institutional ownership of SLQT has decreased, with 259 funds reporting positions, although the put/call ratio indicates a bullish outlook for the stock.
SelectQuote (SLQT) Reports 12% Revenue Growth, Supported Liquidity Through $415M Refinancing
SelectQuote (SLQT) reported a 12% year-over-year revenue increase to $537 million for FQ2 2026, driven by strong performance in its senior segment and SelectRx growth. The company refinanced its debt with a $415 million senior credit facility, extending maturities to 2031, despite lowering its FY2026 guidance due to marketing budget cuts and PBM reimbursement changes. SelectQuote remains confident in its diversified model and negotiating position to navigate market shifts.
SelectQuote (SLQT) Reports 12% Revenue Growth, Supported Liquidity Through $415M Refinancing
SelectQuote Inc. (NYSE:SLQT) reported a 12% year-over-year revenue increase to $537 million for FQ2 2026, driven by strong performance in its senior segment and SelectRx. The company secured a $415 million senior credit facility to support expansion and refinanced debt with extended maturities to 2031. Despite lowering FY2026 guidance due to marketing budget cuts and PBM reimbursement changes, SelectQuote remains confident in its diversified model and secured a new multi-year agreement with a major PBM for greater stability.
